Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).

MLA

“Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).” Annals of Surgery, vol. 277, no. 5, May 2023, pp. e1026–34. EBSCOhost, https://doi.org/10.1097/SLA.0000000000005394.

APA

Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA). (2023). Annals of Surgery, 277(5), e1026–e1034. https://doi.org/10.1097/SLA.0000000000005394

Chicago

“Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA).” 2023. Annals of Surgery 277 (5): e1026–34. doi:10.1097/SLA.0000000000005394.